Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to analyze hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.


Clinical Trial Description

To reduce bleeding, hepatectomies are performed with low central pressure (CVP) combined with extrahepatic control flow.

This management can lead hemodynamic instability and reduction in oxygen delivery so an advanced monitoring should be used.

This study analyzes hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system. ;


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT01627808
Study type Observational
Source Catholic University of the Sacred Heart
Contact
Status Completed
Phase N/A
Start date September 2011
Completion date May 2012

See also
  Status Clinical Trial Phase
Withdrawn NCT05109052 - Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma Phase 1/Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed NCT05030090 - Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer N/A
Terminated NCT00669136 - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma Phase 1
Recruiting NCT04258813 - Onco-primary Care Networking to Support TEAM-based Care N/A
Completed NCT03299036 - Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy N/A
Recruiting NCT03323996 - Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients N/A
Completed NCT02044224 - Effects of Dexmedetomidine During IRE Procedures for Solid Tumours Phase 4
Not yet recruiting NCT03607643 - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Phase 1/Phase 2
Completed NCT05643833 - Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Not yet recruiting NCT03766776 - Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC) N/A
Completed NCT02016391 - Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours Phase 4
Recruiting NCT00730860 - Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE N/A
Terminated NCT00216437 - Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma Phase 1
Completed NCT04172714 - Low-dose Y90 Treatment Planning for HCC N/A
Active, not recruiting NCT03347162 - Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
Completed NCT05907772 - Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma
Recruiting NCT04348838 - Prospective Cohort of Patients With Hepatocellular Carcinoma in France